These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains. Schubert S; Rogers PD; Morschhäuser J Antimicrob Agents Chemother; 2008 Dec; 52(12):4274-80. PubMed ID: 18809934 [TBL] [Abstract][Full Text] [Related]
4. Mrr1 regulation of methylglyoxal catabolism and methylglyoxal-induced fluconazole resistance in Candida lusitaniae. Biermann AR; Demers EG; Hogan DA Mol Microbiol; 2021 Jan; 115(1):116-130. PubMed ID: 33319423 [TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of fluconazole resistance in Candida parapsilosis isolates from a U.S. surveillance system. Grossman NT; Pham CD; Cleveland AA; Lockhart SR Antimicrob Agents Chemother; 2015 Feb; 59(2):1030-7. PubMed ID: 25451046 [TBL] [Abstract][Full Text] [Related]
7. A CTG Clade Candida Yeast Genetically Engineered for the Genotype-Phenotype Characterization of Azole Antifungal Resistance in Human-Pathogenic Yeasts. Accoceberry I; Rougeron A; Biteau N; Chevrel P; Fitton-Ouhabi V; Noël T Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038279 [TBL] [Abstract][Full Text] [Related]
9. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142 [TBL] [Abstract][Full Text] [Related]
10. Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy. Scott NE; Edwin Erayil S; Kline SE; Selmecki A Antimicrob Agents Chemother; 2023 Aug; 67(8):e0054323. PubMed ID: 37428075 [TBL] [Abstract][Full Text] [Related]
11. Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil. Boatto HF; Cavalcanti SD; Del Negro GM; Girão MJ; Francisco EC; Ishida K; Gompertz OF Mem Inst Oswaldo Cruz; 2016 Jun; 111(6):407-10. PubMed ID: 27304096 [TBL] [Abstract][Full Text] [Related]
12. Antifungal drug resistance in pathogenic fungi. Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500 [TBL] [Abstract][Full Text] [Related]
13. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species]. Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972 [TBL] [Abstract][Full Text] [Related]
14. Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans. Morio F; Pagniez F; Besse M; Gay-andrieu F; Miegeville M; Le Pape P Int J Antimicrob Agents; 2013 Nov; 42(5):410-5. PubMed ID: 24051054 [TBL] [Abstract][Full Text] [Related]
15. Comparative Genomics for the Elucidation of Multidrug Resistance in Candida lusitaniae. Kannan A; Asner SA; Trachsel E; Kelly S; Parker J; Sanglard D mBio; 2019 Dec; 10(6):. PubMed ID: 31874914 [TBL] [Abstract][Full Text] [Related]
16. Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis. Berkow EL; Manigaba K; Parker JE; Barker KS; Kelly SL; Rogers PD Antimicrob Agents Chemother; 2015 Oct; 59(10):5942-50. PubMed ID: 26169412 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional Response of Candida auris to the Mrr1 Inducers Methylglyoxal and Benomyl. Biermann AR; Hogan DA mSphere; 2022 Jun; 7(3):e0012422. PubMed ID: 35473297 [TBL] [Abstract][Full Text] [Related]
18. Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system. Moazeni M; Kelidari HR; Saeedi M; Morteza-Semnani K; Nabili M; Gohar AA; Akbari J; Lotfali E; Nokhodchi A Colloids Surf B Biointerfaces; 2016 Jun; 142():400-407. PubMed ID: 26974361 [TBL] [Abstract][Full Text] [Related]
19. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates. Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]